Free Trial
NYSE:INSP

Inspire Medical Systems (INSP) Stock Price, News & Analysis

Inspire Medical Systems logo
$146.59 -3.11 (-2.08%)
Closing price 03:59 PM Eastern
Extended Trading
$146.36 -0.23 (-0.15%)
As of 04:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Inspire Medical Systems Stock (NYSE:INSP)

Key Stats

Today's Range
$144.95
$150.13
50-Day Range
$141.49
$196.66
52-Week Range
$123.00
$257.40
Volume
273,216 shs
Average Volume
591,142 shs
Market Capitalization
$4.36 billion
P/E Ratio
84.73
Dividend Yield
N/A
Price Target
$222.20
Consensus Rating
Moderate Buy

Company Overview

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Remove Ads

Inspire Medical Systems Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
93rd Percentile Overall Score

INSP MarketRank™: 

Inspire Medical Systems scored higher than 93% of companies evaluated by MarketBeat, and ranked 24th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Inspire Medical Systems has received a consensus rating of Moderate Buy. The company's average rating score is 2.70, and is based on 7 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Inspire Medical Systems has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Inspire Medical Systems' stock forecast and price target.
  • Earnings Growth

    Earnings for Inspire Medical Systems are expected to grow by 49.07% in the coming year, from $2.16 to $3.22 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Inspire Medical Systems is 84.73, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.47.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Inspire Medical Systems is 84.73, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 21.73.

  • Price to Earnings Growth Ratio

    Inspire Medical Systems has a PEG Ratio of 2.86. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Inspire Medical Systems has a P/B Ratio of 6.30. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Inspire Medical Systems' valuation and earnings.
  • Percentage of Shares Shorted

    10.26% of the float of Inspire Medical Systems has been sold short.
  • Short Interest Ratio / Days to Cover

    Inspire Medical Systems has a short interest ratio ("days to cover") of 5.2.
  • Change versus previous month

    Short interest in Inspire Medical Systems has recently increased by 0.69%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Inspire Medical Systems does not currently pay a dividend.

  • Dividend Growth

    Inspire Medical Systems does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    10.26% of the float of Inspire Medical Systems has been sold short.
  • Short Interest Ratio / Days to Cover

    Inspire Medical Systems has a short interest ratio ("days to cover") of 5.2.
  • Change versus previous month

    Short interest in Inspire Medical Systems has recently increased by 0.69%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Inspire Medical Systems has a news sentiment score of 1.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.79 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 15 news articles for Inspire Medical Systems this week, compared to 8 articles on an average week.
  • MarketBeat Follows

    Only 4 people have added Inspire Medical Systems to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Inspire Medical Systems insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,794,060.00 in company stock.

  • Percentage Held by Insiders

    Only 4.10% of the stock of Inspire Medical Systems is held by insiders.

  • Percentage Held by Institutions

    94.91% of the stock of Inspire Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Inspire Medical Systems' insider trading history.
Receive INSP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inspire Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

INSP Stock News Headlines

Inspire Medical price target lowered to $210 from $235 at Truist
Trump to unlock 15-figure fortune for America (May 3rd) ?
We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public.
See More Headlines

INSP Stock Analysis - Frequently Asked Questions

Inspire Medical Systems' stock was trading at $185.38 at the beginning of 2025. Since then, INSP shares have decreased by 20.9% and is now trading at $146.5870.
View the best growth stocks for 2025 here
.

Inspire Medical Systems, Inc. (NYSE:INSP) announced its quarterly earnings results on Monday, February, 10th. The company reported $1.15 EPS for the quarter, beating analysts' consensus estimates of $0.74 by $0.41. Inspire Medical Systems had a net margin of 6.67% and a trailing twelve-month return on equity of 8.19%.
Read the conference call transcript
.

Inspire Medical Systems (INSP) raised $75 million in an initial public offering (IPO) on Thursday, May 3rd 2018. The company issued 5,000,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs acted as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.

Inspire Medical Systems' top institutional investors include Congress Asset Management Co. (1.03%), GAMMA Investing LLC (0.31%), Rhumbline Advisers (0.24%) and Lmcg Investments LLC (0.09%). Insiders that own company stock include Timothy P Herbert, Marilyn C Nelson, Richard Buchholz, Shawn Mccormick, Jerry C Griffin, John Rondoni, Randy Ban, Steven Jandrich and Philip Ebeling.
View institutional ownership trends
.

Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Inspire Medical Systems investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), UnitedHealth Group (UNH), Tesla (TSLA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ).

Company Calendar

Last Earnings
2/10/2025
Today
4/15/2025
Next Earnings (Estimated)
5/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NYSE:INSP
Fax
N/A
Employees
1,246
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$222.20
High Stock Price Target
$255.00
Low Stock Price Target
$190.00
Potential Upside/Downside
+51.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.70
Research Coverage
10 Analysts

Profitability

Trailing P/E Ratio
84.73
Forward P/E Ratio
67.86
P/E Growth
2.86
Net Income
$53.51 million
Pretax Margin
7.28%

Debt

Sales & Book Value

Annual Sales
$802.80 million
Cash Flow
$1.40 per share
Price / Cash Flow
104.41
Book Value
$23.25 per share
Price / Book
6.30

Miscellaneous

Free Float
28,453,000
Market Cap
$4.36 billion
Optionable
Optionable
Beta
1.39
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NYSE:INSP) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners